HomeCTX • TSE
add
Crescita Therapeutics Inc
Previous close
$0.46
Year range
$0.45 - $0.64
Market cap
8.58M CAD
Avg Volume
23.20K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 6.23M | 52.47% |
Operating expense | 3.24M | -1.13% |
Net income | 798.00K | 186.18% |
Net profit margin | 12.80 | 156.51% |
Earnings per share | — | — |
EBITDA | 936.00K | 226.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.18M | -9.19% |
Total assets | 21.89M | -4.64% |
Total liabilities | 6.27M | 8.98% |
Total equity | 15.61M | — |
Shares outstanding | 18.87M | — |
Price to book | 0.55 | — |
Return on assets | 6.68% | — |
Return on capital | 9.17% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 798.00K | 186.18% |
Cash from operations | -3.00K | -100.55% |
Cash from investing | -170.00K | 81.36% |
Cash from financing | -175.00K | -10.76% |
Net change in cash | -354.00K | 31.79% |
Free cash flow | -520.12K | -11.82% |
About
Founded
2016
Website
Employees
75
